financetom
Business
financetom
/
Business
/
MasTec's Q2 Adjusted Earnings, Revenue Increase; Updates 2024 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MasTec's Q2 Adjusted Earnings, Revenue Increase; Updates 2024 Guidance
Aug 2, 2024 1:01 AM

03:33 AM EDT, 08/02/2024 (MT Newswires) -- MasTec ( MTZ ) reported Q2 adjusted earnings late Thursday of $0.96 per diluted share, up from $0.89 a year earlier.

Analysts polled by Capital IQ expected $0.87.

Revenue for the quarter ended June 30 was $2.96 billion, up from $2.87 billion a year earlier.

Analysts polled by Capital IQ expected $3.09 billion.

The company expects Q3 adjusted EPS of $1.24 and revenue of $3.45 billion. Analysts surveyed by Capital IQ expect adjusted EPS of $1.21 and revenue of $3.43 billion.

For 2024, the company expects adjusted EPS of $3.03 and revenue of $12.4 billion, compared with previously issued guidance of adjusted EPS of $2.95 and revenue of $12.55 billion. Analysts polled by Capital IQ expect EPS of $2.95 and revenue of $12.55 billion.

Price: 111.42, Change: +5.30, Percent Change: +4.99

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arcus Biosciences Discontinues Phase 3 Lung Cancer Trial for Futility
Arcus Biosciences Discontinues Phase 3 Lung Cancer Trial for Futility
Apr 20, 2026
10:16 AM EDT, 04/20/2026 (MT Newswires) -- Arcus Biosciences ( RCUS ) said Monday it discontinued its phase 3 STAR-121 study in metastatic non-small cell lung cancer after an Independent Data Monitoring Committee recommended stopping the trial for futility. The study, conducted in collaboration with Gilead Sciences ( GILD ) , evaluated domvanalimab plus zimberelimab and chemotherapy versus pembrolizumab plus...
Sila Realty Trust to be Taken Private by Blue Owl Affiliates in $2.4 Billion Deal
Sila Realty Trust to be Taken Private by Blue Owl Affiliates in $2.4 Billion Deal
Apr 20, 2026
10:15 AM EDT, 04/20/2026 (MT Newswires) -- Sila Realty Trust ( SILA ) agreed to be acquired and taken private by certain affiliates of Blue Owl Capital's (OWL) real estate unit in an all-cash deal worth roughly $2.4 billion. Shareholders of net lease real estate investment trust Sila will receive $30.38 per share, representing a 19% premium to the stock's...
Cleveland-Cliffs Beats First-Quarter Forecasts as Loss Narrows; CEO Signals Profit Ahead
Cleveland-Cliffs Beats First-Quarter Forecasts as Loss Narrows; CEO Signals Profit Ahead
Apr 20, 2026
10:43 AM EDT, 04/20/2026 (MT Newswires) -- Cleveland-Cliffs ( CLF ) first-quarter loss narrowed more than expected with revenue exceeding market estimates, while CEO Lourenco Goncalves said the steel producer anticipates a return to profit in the second quarter. The company said Monday its adjusted loss narrowed to $0.40 a share in the March quarter from the loss of $0.93...
Phillips 66, Kinder Morgan move ahead with new US West Coast fuel pipeline
Phillips 66, Kinder Morgan move ahead with new US West Coast fuel pipeline
Apr 20, 2026
April 20 (Reuters) - Phillips 66 and Kinder Morgan ( KMI ) have secured enough long-term shipper commitments to move forward with a proposed pipeline project to supply fuel to Arizona and California, they said on Monday. The Western Gateway Pipeline project comes as companies race to build a major new fuel pipeline to the U.S. West Coast ahead of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved